JASMINE Veterinary Cardiovascular Medical Center, 1-8-37 Nakagawa Tsuzuki-ku, Yokohama, Kanagawa, 224-0001, Japan.
Sci Rep. 2023 Mar 27;13(1):4675. doi: 10.1038/s41598-023-29476-1.
In small-breed dogs, myxomatous mitral valve disease (MMVD) is a common disease which may lead to chronic heart failure. Mitral valve repair is an optimal surgical treatment that is currently available in limited veterinary facilities globally because it requires a special surgery team and specific devices. Therefore, some dogs must travel overseas to undergo this surgery. However, a question arises regarding the safety of dogs when traveling by air with a heart disease. We aimed to evaluate the effect of flight journey on dogs with mitral valve disease, including survival rates, symptoms during the trip, laboratory test results, and operational outcomes. All dogs stayed near the owner in the cabin during the flight. The survival rate after the flight was 97.5% in 80 dogs. The surgical survival rates (96.0% and 94.3%) and hospitalization periods (7 days and 7 days) were similar between overseas and domestic dogs. This report shows that taking air flights in the cabin may not have a significant effect on dogs with MMVD, on the premise that their overall conditions are stable under cardiac medication.
在小型犬中,黏液样变性二尖瓣疾病(MMVD)是一种常见疾病,可能导致慢性心力衰竭。二尖瓣修复是一种理想的手术治疗方法,但目前在全球范围内只有有限的兽医设施能够提供这种治疗,因为它需要特殊的手术团队和特定的设备。因此,一些狗必须前往海外接受这种手术。然而,当患有心脏病的狗乘坐飞机旅行时,安全性问题就出现了。我们旨在评估飞行旅程对患有二尖瓣疾病的狗的影响,包括存活率、旅行过程中的症状、实验室检查结果和手术结果。所有狗在飞行过程中都在机舱内靠近主人的地方。80 只狗在飞行后的存活率为 97.5%。海外和国内的狗的手术存活率(96.0%和 94.3%)和住院时间(7 天和 7 天)相似。本报告表明,在心脏药物治疗下,整体状况稳定的前提下,乘坐机舱内的航班可能不会对患有 MMVD 的狗产生重大影响。